The imbalance of neurotransmitters, resulting in a surplus of dopaminergic and deficit of cholinergic transmission, has provided the historic rationale for the use of antipsychotics (dopamine D2 receptor antagonists) in delirium over the last two decades [25,33]. The gene discussed is DRD2; the disease is delirium.